Tag: VepdegestrantWinsFDA
Vepdegestrant Wins FDA Nod for ER+ Breast Cancer
Vepdegestrant, a newly approved anti-cancer medication, has marked a significant development in the treatment of breast cancer. As of May 2026, Vepdegestrant, sold under the...




























